Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002159719 | SCV002331528 | likely benign | Noonan syndrome 9 | 2021-08-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003161343 | SCV003857643 | uncertain significance | Cardiovascular phenotype | 2023-05-18 | criteria provided, single submitter | clinical testing | The c.680C>G (p.A227G) alteration is located in exon 5 (coding exon 5) of the SOS2 gene. This alteration results from a C to G substitution at nucleotide position 680, causing the alanine (A) at amino acid position 227 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |